09:03 AM EDT, 04/11/2024 (MT Newswires) -- Western pharmaceutical companies Eli Lilly ( LLY ) , Vertex Pharmaceuticals ( VRTX ) and BeiGene ( BGNE ) are seeking alternative suppliers amid the proposed Biosecure Act in the US that would forbid US firms getting federal grant money from working with four Chinese biotech companies, including WuXi AppTec and WuXi Biologics,...

On Wednesday, Vertex Pharmaceuticals Incorporated ( VRTX ) agreed to acquire Alpine Immune Sciences Inc ( ALPN ) for $65 per share or approximately $4.9 billion in cash.  Alpine’s lead molecule, povetacicept (ALPN-303), is a highly potent and effective dual antagonist of BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand).  Through Phase 2 development, povetacicept has shown potential best-in-class efficacy in IgA...

April 11 (Reuters) - Swiss drugmaker Novartis AG has entered into a licensing deal worth up to $1.01 billion with Arvinas ( ARVN ) to gain access to the U.S. biotech firm's experimental prostate cancer drug, Arvinas ( ARVN ) said on Thursday. Shares of Connecticut-based Arvinas ( ARVN ) rose more than 6% to $39 in premarket trade. The...

MILAN, April 11 (Reuters) - Activist investor Bluebell Capital Partners is proposing to nominate an outgoing Google executive as candidate for the role of CEO of Telecom Italia (TIM), in a challenge to Pietro Labriola's bid for a second term. In a document presenting Bluebell's vision for TIM, seen by Reuters, it proposed Laurence Lafont, the outgoing vice-president for strategic...